Evidence review

Thymosin Alpha-1 and Biologic Therapies

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `thymosin-alpha-1-biologics`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/thymosin-alpha-1-biologics

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/thymosin-alpha-1-biologics/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/thymosin-alpha-1-biologics/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/thymosin-alpha-1-biologics/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/thymosin-alpha-1-biologics/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Thymosin Alpha-1 might help you

  1. Therefore for you: If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Thymosin Alpha-1 → immune modulation

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 17
  • Claims tagged human evidence: 14
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 39
  • Reddit posts catalogued: 36
  • X posts catalogued: 4
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 57

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials (source s1)

2024 review of >30 human trials, >11k subjects; concludes well-tolerated modulator.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin alpha 1: A comprehensive review of the literature (source s2)

2020 review covering clinical applications in hepatitis, HIV, cancer.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression (source s3)

Meta-analysis showing mortality reduction and immune marker changes in human trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Immune Modulation with Thymosin Alpha 1 Treatment (source s4)

Notes preclinical mouse model origin.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Phenotypic drug discovery: a case for thymosin alpha-1 (source s5)

2024 review exploring Ta1 in preclinical/clinical settings, combinations with chemo/radiotherapy, and approvals in multiple countries for infections and cancer.

Evidence type: Published research.

Aging and Thymosin Alpha-1 (source s6)

2025 article on Ta1 for immune restoration in aging, listing biologics among related topics.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of ... (source s7)

Ongoing trial testing Ta1 as immune enhancer, relevant to biologic/therapy contexts.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis (source s10)

2025 systematic review and meta-analysis showing Tα1 increases CD4+ cells, improves CD4+/CD8+ ratio, reduces CRP in lower doses, reduces extrapancreatic infections, and lowers APACHE II score in severe acute pancreatitis patients.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma (source s11)

Ongoing clinical trial evaluating Thymosin Alpha-1 combined with anti-PD-1 therapy in elderly advanced melanoma patients (posted 2026).

Evidence type: Published research.

Protective Effect of Ulinastatin and Thymosin α1 Against Postoperative Complications in Elderly Patients With Colorectal Cancer (source s12)

Clinical trial on combined ulinastatin and thymosin α1 for reducing postoperative complications in elderly colorectal cancer patients.

Evidence type: Published research.

Thymosin α1 Elevates Lymphocyte Counts and Improves Immunoradiotherapy Response in Patients Receiving PD-1 Inhibitors (source s13)

Recent PubMed study on Thymosin α1 enhancing lymphocyte counts and response to PD-1 inhibitor-based immunoradiotherapy in advanced cancers.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: A case report and literature review (source s14)

Case report and review on combining PD-1 inhibitor (biologic) with thymosin alpha-1 and other agents in metastatic breast cancer.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced non-small cell lung cancer: a multicenter Phase II clinical trial (source s15)

Multicenter Phase II trial results on PD-1 inhibitor plus thymosin-α1 combination therapy in advanced NSCLC.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

A Case Report of a Multisystemic Immune-Related Adverse Event Induced by a PD-1 Inhibitor in Combination with Thymosin Alpha-1 (source s16)

Case report detailing immune-related adverse events from PD-1 inhibitor combined with thymosin alpha-1.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Interferon-α and thymosin-α1 plus tislelizumab enhance the efficacy in pancreatic ductal adenocarcinoma (source s17)

Study on interferon-α, thymosin-α1 plus tislelizumab (PD-1 inhibitor) enhancing efficacy in pancreatic cancer.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study (source s18)

Retrospective study on thymosin alpha-1 combined with lenvatinib plus sintilimab (PD-1 inhibitor) in unresectable HCC.

Evidence type: Published research.

Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma (source s19)

New Phase II clinical trial investigating neoadjuvant Thymalfasin (Thymosin Alpha-1) combined with PD-1 inhibitor and chemoradiotherapy in gastroesophageal junction adenocarcinoma.

Evidence type: Published research.

What people say on Reddit

Thymosin alpha 1 peptide? — Reddit, r/ankylosingspondylitis (source s8)

User discussion on using Ta1 peptide alongside or vs. biologics for ankylosing spondylitis, with mixed experiences.

Peptides for RA while on prescribed immune modulator? — Reddit, r/rheumatoid (source s9)

Anecdotal report of Ta1 use with RA treatments including immune modulators.

Anyone here on peptides? BPC-157 specifically? — Reddit, r/ankylosingspondylitis (source s20)

User reports partial flare reduction with TA-1 (anecdotal, not advice), notes it stops working between doses; in context of AS and biologics discussion.

Thymosin Alpha-1 — Reddit, r/PeptideDiscussion (source s21)

Positive anecdotal outcome for skin and arthritis symptoms; user states TA-1 worked better than biologic (anecdotal, not advice).

Peptide injections? — Reddit, r/rheumatoid (source s22)

User reports incredible long-term benefit from Thymosin Alpha-1 approved by doctor (anecdotal, not advice); contrasts with biologics context.

Peptide injections? — Reddit, r/rheumatoid (source s23)

User reports normalized inflammatory markers with TA-1 + HCQ stack (anecdotal, not advice) in RA discussion involving biologics.

Peptides for AS — Reddit, r/ankylosingspondylitis (source s24)

Thread discusses peptides including TA-1 as alternatives or adjuncts to biologics for AS symptoms (anecdotal mentions).

Thymosine Alpha 1 and Psoriasis Biologics — Reddit, r/Biohackers (source s26)

Reddit thread discussing combining Thymosin Alpha-1 with psoriasis biologic Tremfya; anecdotal interest in immune modulation alongside prescribed biologics.

5 Years Long Covid - Thymosin Alpha 1 Peptide - WOW! — Reddit, r/covidlonghaulers (source s27)

Detailed anecdotal report of TA-1 dosing at 500mcg, positive outcomes for long COVID symptoms and hair regrowth, effects lasting 48-72 hours (anecdotal, not advice).

Peptide called Thymosin Alpha 1 is resolving my MCAS — Reddit, r/MCAS (source s28)

Anecdotal positive reports of TA-1 helping MCAS symptoms like alcohol tolerance; some note it works only while using (anecdotal, not advice).

Anyone get side effects/an immune reaction to Thymosin-Alpha 1? — Reddit, r/covidlonghaulers (source s29)

Anecdotes of flu-like side effects from 0.5mg TA-1 dose, interpreted as immune activation; dosing protocol mentions 6 weeks with waves (anecdotal, not advice).

be careful about thymosin alpha-1 — Reddit, r/cfs (source s30)

Warning post about potential negative experiences/side effects with TA-1 in CFS context (anecdotal).

Thymosin Alpha 1 — Reddit, r/smallfiberneuropathy (source s31)

Discussion of potential mixed outcomes (better, no change, or worse) with TA-1 in small fiber neuropathy (anecdotal, not advice).

Peptides — Reddit, r/rheumatoid (source s32)

User describes using TA1 as adjunct to RA meds including biologics context, notes it as immune modulator but not replacement (anecdotal).

Behcets and Peptides? — Reddit, r/Behcets (source s33)

Discussion of TA1 for Behcet's and other autoimmunes, mentions clinical trial, safety (anecdotal intent to try).

Peptides for psoriasis? — Reddit, r/Psoriasis (source s34)

Anecdotal report of TA1 dosing and benefits for psoriasis/skin (anecdotal, not advice).

What people say on X

LL-37, Thymosin Alpha-1, and BPC-157 are resetting immune ... — X (source s25)

Post claims TA-1 helps reset immune system for autoimmune conditions like RA (anecdotal context, not advice).

X post on TA-1 classification — X (source s51)

X post explicitly linking Thymosin Alpha-1 to biologic/immunotherapy category.

Thymosin alpha-1 is one of the more promising peptides ... — X (source s56)

Post on TA1 for immune regulation, in broader peptide context potentially relating to biologic therapies (anecdotal discussion).

Thymosin alpha 1 doesn't behave like a traditional single- ... — X (source s57)

X post describing TA1 mechanism as non-traditional, relevant to immune/biologic comparisons (anecdotal).

What we do not know

  1. There is no direct comparison of Thymosin Alpha-1 to specific biologic therapies in terms of their effects on immune function or side effects.

Safety and limits

  1. No human trials directly compare Tα1 to specific biologic therapies.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

biologics · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpThymosin Alpha-1: Immune Modulation · 23 humanThymosin Alpha 1 for Chemotherapy: Immune Modulation Evidence · 6 humanThymosin Alpha 1 and Gabapentin: What the Evidence Shows on Immune Pat… · 4 humanThymosin Alpha 1 and Corticosteroid Injections: Immune Modulation Evid… · 3 human
Evidence · 57 sources · swipe →chain 5018fb3a6c41 · verify chain · provenance
1 / 57
Evidence ledger 59 · tier-ranked · API
human
No human trials directly compare Tα1 to specific biologic therapies.
human
A 2020 comprehensive literature review summarized Tα1 use in viral hepatitis, HIV, and malignancies with effects on restoring or enhancing immune function.
sources: s2
human
Systematic reviews and meta-analyses of randomized trials in sepsis and COVID-19 reported changes in immune cell markers (e.g., CD4+ T cells, HLA-DR) and reduced mortality in some analyses.
sources: s3
human
Human trial data on Tα1 document context-dependent effects on immune cell subsets without uniform suppression.
sources: s1, s2
human
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
53 more ranked claims
human0.80
There is no direct comparison of Thymosin Alpha-1 to specific biologic therapies in terms of their effects on immune function or side effects.
kimi-collaborator
This claim identifies a specific gap in the evidence regarding the comparison of Thymosin Alpha-1 to biologic therapies, which is supported by the sourced review in s1.
sources: s1
human0.80
2025 systematic review and meta-analysis showing Tα1 increases CD4+ cells, improves CD4+/CD8+ ratio, reduces CRP in lower doses, reduces extrapancreatic infections, and lowers APACHE II score in severe acute pancreatitis patients.
grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
preclinical0.50
Early isolation of Tα1 occurred in thymectomized mouse models where it restored immune function.
grok/4.3-populate
Distinguishes preclinical from human data.
sources: s4
mechanistic0.40
While biologic therapies can result in broad immunosuppression, the specific mechanisms and extent of this effect can vary widely depending on the therapy and individual patient factors.
kimi/moonshot-v1-8k (adversary)
The claim c1 overgeneralizes the side effects of biologic therapies. The counter-evidence from the reviews s1 and s2 indicates that the effects on immune function can be context-dependent and vary among different biologics and patient populations.
system0.35
Thymosin Alpha-1 and Biologic Therapies is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
human0.22low confidence
2025 article on Ta1 for immune restoration in aging, listing biologics among related topics.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
human0.22
Ongoing trial testing Ta1 as immune enhancer, relevant to biologic/therapy contexts.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
human0.22low confidence
Recent PubMed study on Thymosin α1 enhancing lymphocyte counts and response to PD-1 inhibitor-based immunoradiotherapy in advanced cancers.
grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
human0.22low confidence
Case report and review on combining PD-1 inhibitor (biologic) with thymosin alpha-1 and other agents in metastatic breast cancer.
grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
human0.22low confidence
Multicenter Phase II trial results on PD-1 inhibitor plus thymosin-α1 combination therapy in advanced NSCLC.
grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
human0.22low confidence
Case report detailing immune-related adverse events from PD-1 inhibitor combined with thymosin alpha-1.
grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
human0.22low confidence
Study on interferon-α, thymosin-α1 plus tislelizumab (PD-1 inhibitor) enhancing efficacy in pancreatic cancer.
grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
mechanistic0.22low confidence
Retrospective study on thymosin alpha-1 combined with lenvatinib plus sintilimab (PD-1 inhibitor) in unresectable HCC.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User discussion on using Ta1 peptide alongside or vs. biologics for ankylosing spondylitis, with mixed experiences.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Anecdotal report of Ta1 use with RA treatments including immune modulators.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
Anecdotal reports from users on platforms like Reddit suggest varying experiences when using Thymosin Alpha-1 in conjunction with biologic therapies, but these are not systematically collected or analyzed.
kimi-collaborator
This claim aggregates anecdotal evidence from user discussions on Reddit, which are mentioned in the sources s8 and s9, to provide a more comprehensive view of who claims what regarding the use of Thymosin Alpha-1 with biologic therapies.
sources: s8, s9
anecdotal0.22low confidence
User reports partial flare reduction with TA-1 (anecdotal, not advice), notes it stops working between doses; in context of AS and biologics discussion.
grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22low confidence
Positive anecdotal outcome for skin and arthritis symptoms; user states TA-1 worked better than biologic (anecdotal, not advice).
grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22low confidence
User reports incredible long-term benefit from Thymosin Alpha-1 approved by doctor (anecdotal, not advice); contrasts with biologics context.
grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22low confidence
User reports normalized inflammatory markers with TA-1 + HCQ stack (anecdotal, not advice) in RA discussion involving biologics.
grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22low confidence
Thread discusses peptides including TA-1 as alternatives or adjuncts to biologics for AS symptoms (anecdotal mentions).
grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22low confidence
Post claims TA-1 helps reset immune system for autoimmune conditions like RA (anecdotal context, not advice).
grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
Reddit thread discussing combining Thymosin Alpha-1 with psoriasis biologic Tremfya; anecdotal interest in immune modulation alongside prescribed biologics.
grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22low confidence
Detailed anecdotal report of TA-1 dosing at 500mcg, positive outcomes for long COVID symptoms and hair regrowth, effects lasting 48-72 hours (anecdotal, not advice).
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22low confidence
Anecdotal positive reports of TA-1 helping MCAS symptoms like alcohol tolerance; some note it works only while using (anecdotal, not advice).
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22low confidence
Anecdotes of flu-like side effects from 0.5mg TA-1 dose, interpreted as immune activation; dosing protocol mentions 6 weeks with waves (anecdotal, not advice).
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
Warning post about potential negative experiences/side effects with TA-1 in CFS context (anecdotal).
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
Discussion of potential mixed outcomes (better, no change, or worse) with TA-1 in small fiber neuropathy (anecdotal, not advice).
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22low confidence
User describes using TA1 as adjunct to RA meds including biologics context, notes it as immune modulator but not replacement (anecdotal).
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.22low confidence
Anecdotal report of TA1 dosing and benefits for psoriasis/skin (anecdotal, not advice).
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
User mentions avoiding biologics, using TA1 for HS immune modulation (anecdotal).
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22low confidence
Thread on peptides for unknown autoimmune, related to TA1 discussions (anecdotal).
grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22low confidence
User reports putting Hashimoto's into remission with TA-1 after trying biologics like Humira (anecdotal positive outcome).
grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22low confidence
Thread discusses TA-1 peptides while on Enbrel biologic for RA; mentions flaring on biologic (anecdotal, mixed context).
grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
anecdotal0.22low confidence
User considering TA-1 peptides alongside starting biosimilar Humira biologic for RA (anecdotal discussion of combination).
grok-4.3
Materialized from orphan source s39 by ledger repair
sources: s39
anecdotal0.22low confidence
Discussion on studies for TA-1 in Long COVID/ME/CFS, noting its immunomodulatory potential (anecdotal context, not advice).
grok-4.3
Materialized from orphan source s40 by ledger repair
sources: s40
anecdotal0.22low confidence
Compares TA-1 to thymalin, notes pharmaceutical approval of Zadaxin (anecdotal dosing/uses discussed elsewhere in thread).
grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
Anecdotal report of TA-1 worsening TPO antibodies in Hashimoto's (bad outcome, not advice); dosing discussion in thread.
grok-4.3
Materialized from orphan source s43 by ledger repair
sources: s43
anecdotal0.22low confidence
Anecdotal positive lab changes with TA-1 in CIRS (good outcome, side effects like herx mentioned); dosing 100-400mcg 2-3x/week (anecdotal, not advice).
grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
anecdotal0.22low confidence
Anecdotal positive experience with TA-1 microdosing for MCAS (good outcome, not advice).
grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
anecdotal0.22low confidence
Reddit thread in r/cfs discussing TA-1 for EBV/CFS, FDA concerns on immunogenicity, and anecdotal dosing advice of twice weekly to avoid overstimulation (anecdotal, not advice).
grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Reddit post exploring TA-1 (Zadaxin) for Hashimoto's immune modulation, context of autoimmune therapies.
grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
anecdotal0.22low confidence
Discussion of TA-1 as immunomodulator alternative in autoimmune hair loss context (anecdotal interest, not advice).
grok-4.3
Materialized from orphan source s48 by ledger repair
sources: s48
anecdotal0.22low confidence
Detailed Reddit thread on TA-1 dosing regimens (twice weekly 1.6mg SC per Zadaxin guidelines) vs daily, with pharmacokinetic quotes (anecdotal discussion only).
grok-4.3
Materialized from orphan source s49 by ledger repair
sources: s49
anecdotal0.22low confidence
Positive anecdotal user experiences with TA-1 in women's peptides community (anecdotal, not advice).
grok-4.3
Materialized from orphan source s50 by ledger repair
sources: s50
anecdotal0.22low confidence
X post explicitly linking Thymosin Alpha-1 to biologic/immunotherapy category.
grok-4.3
Materialized from orphan source s51 by ledger repair
sources: s51
anecdotal0.22low confidence
User on biologics for psoriasis discusses peptides including thymosin alpha-1 as potentially helpful for immune response alongside biologics; notes personal management without biologics using KPV and TA1 for reduced inflammation (anecdotal).
grok-4.3
Materialized from orphan source s52 by ledger repair
sources: s52
anecdotal0.22low confidence
Anecdotal report of TA1 + KPV reducing psoriasis inflammation (no biologics used); another user asks about combining with Tremfya biologic (anecdotal, not advice).
grok-4.3
Materialized from orphan source s53 by ledger repair
sources: s53
anecdotal0.22low confidence
Discussion of TA1 regulatory status and immune modulation uses, in context of compounding and potential biologic-like applications (anecdotal context only).
grok-4.3
Materialized from orphan source s54 by ledger repair
sources: s54
anecdotal0.22low confidence
Suggestion of TA1 as alternative or adjunct in RA discussion involving biologics (anecdotal).
grok-4.3
Materialized from orphan source s55 by ledger repair
sources: s55
anecdotal0.22low confidence
Post on TA1 for immune regulation, in broader peptide context potentially relating to biologic therapies (anecdotal discussion).
grok-4.3
Materialized from orphan source s56 by ledger repair
sources: s56
anecdotal0.22low confidence
X post describing TA1 mechanism as non-traditional, relevant to immune/biologic comparisons (anecdotal).
grok-4.3
Materialized from orphan source s57 by ledger repair
sources: s57
mechanistic0.15
Biologic therapies commonly target specific immune pathways, which can result in broad immunosuppression as a side effect.
grok/4.3-populate
Establishes the problem framing for the article.
Low-confidence / auto-generated 1
speculative0.12
Commercial vendors and clinics market this compound (7 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 10 duplicate marketing claims
sources: s1, s5, s11, s12, s19, s33, s42
Model swipes · 17 from 5 models · swipe →verify
1 / 17
grok/grok-4.3writer
redraft2026-06-29 09:28
Thymosin Alpha-1 and Biologic Therapies · 7 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "thymosin-alpha-1-and-biologic-therapies",
  "title": "Thymosin Alpha-1 and Biologic Therapies",
  "body": "## Biologics and Immune Suppression\n\nBiologic therapies commonly target specific immune pathways, which can result in broad immunosuppression as a side effect.\n\n## Thymosin Alpha-1 Overview\n\nThymosin Alpha-1 (Tα1) is a 28-amino-acid peptide derived from the thymus. Human clinical trials have examined its role in immune modulation across multiple conditions.\n\n## Human Clinical Data on Immune Modulation\n\nA 2024 narrative review of clinical studies involving over 11,000 human subjects across more than 30 trials described Tα1 as a well-tolerated immune modulator (human tier). A 2020 comprehensive literature review summarized its use in conditions including viral hepatitis, HIV, and malignancies, noting effects on restoring or enhancing aspects of immune function (human tier).\n\nMultiple systematic reviews and meta-analyses of randomized trials in sepsis and COVID-19 reported changes in immune cell markers such as increased CD4+ T cells or HLA-DR expression alongside reduced mortality in some pooled analyses (human tier).\n\n## Preclinical Context\n\nEarly isolation of Tα1 occurred in thymectomized mouse models, where it restored immune function (preclinical tier).\n\n## Repair-vs-Suppression Framing\n\nBiologic agents often act via targeted pathway inhi
b44a5ffac2325c3a
grok-4.3source_hunt
sources2026-06-29 11:34
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
5 source(s) added
e27b681910e1c45a
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
{"materialized":0,"before":[],"after":[]}
9ceecb11601eb54d
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
{"materialized":0,"before":[],"after":[]}
0394094054d49470
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
{"materialized":0,"before":[],"after":[]}
e6c7240cf912f618
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
{"materialized":0,"before":[],"after":[]}
5346e1e932320e14
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 14:10
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
I am adding explicit gaps in knowledge regarding the comparison of Thymosin Alpha-1 to biologic therapies and naming who claims what from anecdotes, as instructed. I am not Grok because I am following the instructions to add claims that are tier-honest and filling in the gaps that the ledger currently lacks.
22863e4510078bda
grok-4.3source_hunt
sources2026-06-29 14:57
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
7 source(s) added
11e01b02ab37b159
grok-4.3source_hunt
sources2026-06-29 14:57
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
7 source(s) added
670ff9b4b43139cf
grok-4.3source_hunt
sources2026-06-29 18:44
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
6 source(s) added
2dc845764ce20802
grok-4.3source_hunt
sources2026-06-29 18:44
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
6 source(s) added
0065baa25fe98209
grok-4.3source_hunt
sources2026-06-29 18:45
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
5 source(s) added
7d9cd9a86ccf8a3b
grok-4.3source_hunt
sources2026-06-29 18:46
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
6 source(s) added
8d53ffc7989653f3
grok-4.3source_hunt
sources2026-06-29 18:46
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
6 source(s) added
d07a017cdc5334de
grok-4.3source_hunt
sources2026-06-29 18:47
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
6 source(s) added
ba687c9634af7841
grok-4.3source_hunt
sources2026-06-29 18:48
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics
it output
6 source(s) added
f970838ce5d210cd
fill-slotsclaim_post
claim2026-06-29 21:22
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: thymosin-alpha-1-biologics c68
it output
Thymosin Alpha-1 and Biologic Therapies is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
5a48d37528e6ff01

Related research

biologics · condition map

Open evidence map →
Thymosin Alpha-1: Immune Modulationembedded in this articlethymosin-alpha-1Thymosin Alpha 1 for Benzodiazepine Withdrawal: Evidence-Graded Reviewthymosin-alpha-1-benzo-withdrawalThymosin Alpha 1 for Benzodiazepines: Evidence Reviewthymosin-alpha-1-benzodiazepinesThymosin Alpha-1 for Statin-Associated Cognitive Effects: Evidence Rev…thymosin-alpha-1-brain-fogThymosin Alpha-1 for Carpal Tunnel Syndrome: Evidence Reviewthymosin-alpha-1-carpal-tunnelThymosin Alpha 1 for Chemotherapy: Immune Modulation Evidencethymosin-alpha-1-chemoThymosin Alpha 1 for Chemotherapy-Induced Neuropathy: Evidence Reviewthymosin-alpha-1-chemo-neuropathyThymosin Alpha 1 for Cognition: Evidence on Immune Modulation and Brai…thymosin-alpha-1-cognitionThymosin Alpha 1 and Corticosteroid Injections: Immune Modulation Evid…thymosin-alpha-1-corticosteroidsThymosin Alpha 1 for Diabetic Neuropathy: Evidence Reviewthymosin-alpha-1-diabetic-neuropathy
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human trials directly compare Tα1 to specific biologic therapies."?
ask thymosin-alpha-1-biologics claim c7 · paste includes §SELF
What does the ledger say about this (human tier): "A 2020 comprehensive literature review summarized Tα1 use in viral hepatitis, HIV, and malignancies with effects on restoring or enhancing i…"?
ask thymosin-alpha-1-biologics claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Systematic reviews and meta-analyses of randomized trials in sepsis and COVID-19 reported changes in immune cell markers (e.g., CD4+ T cells…"?
ask thymosin-alpha-1-biologics claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "Human trial data on Tα1 document context-dependent effects on immune cell subsets without uniform suppression."?
ask thymosin-alpha-1-biologics claim c6 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask thymosin-alpha-1-biologics claim c16 · paste includes §SELF
What does the ledger say about this (human tier): "There is no direct comparison of Thymosin Alpha-1 to specific biologic therapies in terms of their effects on immune function or side effect…"?
ask thymosin-alpha-1-biologics claim c17 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User discussion on using Ta1 peptide alongside or vs. biologics for ankylosing spondylitis, with mixed experiences."
ask thymosin-alpha-1-biologics source s8 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Anecdotal report of Ta1 use with RA treatments including immune modulators."
ask thymosin-alpha-1-biologics source s9 · paste includes §SELF
thymosin-alpha-1-biologics · posted 2026-06-29 · updated 2026-06-29 · 22 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 22 model passes · 3576 tokens · $0 · 6 models
chain head 0929d34c6b498bbb
write grok/grok-4.3 · 2026-06-29 09:28 · 0 tok · c7ceac19cc5e
sources grok-4.3 · 2026-06-29 11:34 · 0 tok · 9a87354690b8
repair system/audit-repair · 2026-06-29 12:49 · 0 tok · 7a21453b9cd4
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 424b141a8d2b
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 28e97dc0d2c9
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 673f46990e50
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 9e08a8647404
repair system/audit-repair · 2026-06-29 12:49 · 0 tok · bc0ab3f35315
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · c960466ad12c
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · a9aeca8866f9
collaborate kimi/moonshot-v1-8k · 2026-06-29 14:10 · 3576 tok · feb3562e12cc
sources grok-4.3 · 2026-06-29 14:57 · 0 tok · b0289fcfba45
sources grok-4.3 · 2026-06-29 14:57 · 0 tok · 2c67c9ab1086
sources grok-4.3 · 2026-06-29 18:44 · 0 tok · b81b5fb9350a
sources grok-4.3 · 2026-06-29 18:44 · 0 tok · 5357bc9d03bb
sources grok-4.3 · 2026-06-29 18:45 · 0 tok · 324d3c101b65
sources grok-4.3 · 2026-06-29 18:46 · 0 tok · dc57d74643e4
sources grok-4.3 · 2026-06-29 18:46 · 0 tok · 57a6137673b6
sources grok-4.3 · 2026-06-29 18:47 · 0 tok · 2a021916f665
sources grok-4.3 · 2026-06-29 18:48 · 0 tok · 58ded4da9602
repair repair · 2026-06-29 20:11 · 0 tok · 7cfeba8c49a2
claim fill-slots · 2026-06-29 21:22 · 0 tok · 0929d34c6b49
verify chain →
Live ledger · 44 payloads · 9 turns
recent activity · inspect
webhook_in blooio · 2026-06-29 18:49
webhook_in blooio · 2026-06-29 18:49
PROTOCOL_RUN dispatch · 2026-06-29 18:49 · t_tjyhdwja
PROTOCOL_RUN dispatch · 2026-06-29 18:49 · t_tjyhdwja
webhook_in blooio · 2026-06-29 18:49
webhook_in blooio · 2026-06-29 18:49
view full ledger & cards →
REST + ledger
read GET /api/articles/thymosin-alpha-1-biologics · GET /api/articles/thymosin-alpha-1-biologics?format=post (the editable body)
create/replace POST /api/articles/thymosin-alpha-1-biologics · PUT /api/articles/thymosin-alpha-1-biologics (replace, keeps revision) · PATCH /api/articles/thymosin-alpha-1-biologics (merge)
delete DELETE /api/articles/thymosin-alpha-1-biologics
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/thymosin-alpha-1-biologics/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/thymosin-alpha-1-biologics/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim thymosin-alpha-1-biologics|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →